Kenya's HIV Prevention Crisis: Why Oral PrEP Is Failing High-Risk Groups
Kenya's HIV Prevention Crisis: Why Oral PrEP Is Failing High-Risk Groups
Will Lenacapavir be the silver bullet in fight against HIV?
Kenya's HIV Prevention Crisis: Why Oral PrEP Is Failing High-Risk Groups
In 2016, Kenya was hailed as a global pioneer for rolling out daily Oral PrEP. Fast forward to 2026, and the data tells a more sobering story. According to the NSDCC 2025 Report, new HIV infections in Kenya surged by 19 per cent last year, reaching 20,000 cases.
Despite having initiated over 544,000 people on oral PrEP, we have hit a structural ceiling. The "daily pill" model is failing our most vulnerable.
U.S. Launches Bold Plan to Tackle Hepatitis C Racial Disparities
Millions face silent liver damage from untreated hepatitis C—yet not everyone gets equal care. A federal push aims to change that. The virus kills thousands yearly, but a cure exists. Why are some still left behind?
Eastern Germany's First Family-Centered Pediatric Heart Clinic Opens in Strausberg
A lifeline for families with sick children arrives in Brandenburg. This pioneering clinic combines medical care with emotional support—all under one roof.
Businessman's Shock Bladder Cancer Diagnosis Sparks Advocacy and Hope
A routine checkup turned Warren Klein's life upside down. Now, he's turning his battle into a mission to save others from late-stage bladder cancer.
How smoking silently destroys your heart and blood vessels
Every cigarette weakens your heart in hidden ways. From clogged arteries to fatal clots, the damage builds long before symptoms appear.